Skip to main content
Equibles

Freestone Capital Holdings, LLC

Position in EXEL — Exelixis, Inc.

CIK 1470876 Seattle, WA
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$379,455
+$79,183 QoQ
Shares Held
6,974
-0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#485
of 757 holders
Holding Since
Sep 2020
3 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Freestone Capital Holdings, LLC holds $7,262,289 across 14 Biotechnology names. EXEL ranks #8 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABUS
Arbutus Biopharma Corp
 442,500 $2,124,000
2 IMNM
Immunome Inc.
 60,589 $1,283,880
3 BNTX
BioNTech SE
 7,914 $736,397
4 REGN
Regeneron Pharmaceuticals, Inc.
 904 $563,680
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,004 $498,716
6 RYTM
Rhythm Pharmaceuticals, Inc.
 3,700 $410,811
7 RVMD
Revolution Medicines, Inc.
 2,109 $394,973
8 EXEL
Exelixis, Inc.
This page 		6,974 $379,455

All Filings in EXEL

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $379,455 6,974
2026-03-31 $300,272 7,001
2020-09-30 $6,821 279